|
28 Companies |
|
20 Products |
|
20 Products |
|
0 Mechanisms of Action |
|
56 Trials |
|
636 News |
|
| «1234567891011» |
- propranolol / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response (clinicaltrials.gov) - Oct 4, 2016
P=N/A, N=0, Withdrawn, Sponsor: University of Missouri-Columbia
N=30 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Nov 2018 --> Sep 2016
- New trial: A2MT: a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - Sep 29, 2016
P=N/A, N=40, Recruiting, Sponsor: Northumbria University
- | oxytocin intranasal (OPN-300) / OptiNose
Trial completion: Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder (clinicaltrials.gov) - Sep 27, 2016
P1/2, N=17, Completed, Sponsor: OptiNose AS
N=30 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Nov 2018 --> Sep 2016 Recruiting --> Completed
- Trial completion, Trial primary completion date: Stem Cell Therapy in Autism Spectrum Disorders (clinicaltrials.gov) - Sep 26, 2016
P1, N=162, Completed, Sponsor: Neurogen Brain and Spine Institute
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Jan 2016
- Trial completion: Internet Delivered CBT for OCD in Adolescents With ASD - A Clinical Case Series (clinicaltrials.gov) - Sep 7, 2016
P=N/A, N=4, Completed, Sponsor: Karolinska Institutet
Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Jan 2016 Recruiting --> Completed
- Enrollment open: Build Your Parenting Toolkit: Guiding Children to Become Flexible Thinkers (clinicaltrials.gov) - Sep 1, 2016
P=N/A, N=8, Recruiting, Sponsor: Rehabilitation Centre for Children, Canada
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change, Trial initiation date, Trial withdrawal: Cortical Metrics in Intervention Trials With Autism Spectrum Disorders (clinicaltrials.gov) - Aug 25, 2016
P2/3, N=0, Withdrawn, Sponsor: Duke University
Not yet recruiting --> Recruiting N=60 --> 0 | Initiation date: Jul 2014 --> Aug 2015 | Recruiting --> Withdrawn
- Trial completion, Enrollment change: Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders (clinicaltrials.gov) - Aug 25, 2016
P=N/A, N=10, Completed, Sponsor: Yale University
N=60 --> 0 | Initiation date: Jul 2014 --> Aug 2015 | Recruiting --> Withdrawn Recruiting --> Completed | N=40 --> 10
- Trial completion, Enrollment change: Using Video Modeled Social Stories to Improve Oral Hygiene in Children With Autism Spectrum Disorder (clinicaltrials.gov) - Aug 8, 2016
P=N/A, N=19, Completed, Sponsor: Yale University
Recruiting --> Completed | N=40 --> 10 Active, not recruiting --> Completed | N=40 --> 19
- ||| balovaptan (RG7314) / Roche
Enrollment closed: VANILLA: A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) (clinicaltrials.gov) - Aug 2, 2016
P2, N=223, Active, not recruiting, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed | N=40 --> 19 Recruiting --> Active, not recruiting
- Enrollment open: Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety (clinicaltrials.gov) - Aug 2, 2016
P=N/A, N=40, Recruiting, Sponsor: Emory University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial primary completion date: DOUPA: Pain in Adults With Autism Spectrum Disorder (clinicaltrials.gov) - Jul 28, 2016
P=N/A, N=90, Recruiting, Sponsor: University Hospital, Brest
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2016 --> May 2017
- sodium valproate / Generic mfg.
Enrollment change, Trial primary completion date: Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium (clinicaltrials.gov) - Jul 26, 2016
P2, N=10, Recruiting, Sponsor: Children's Hospital Boston
Trial primary completion date: Jun 2016 --> May 2017 N=30 --> 10 | Trial primary completion date: Apr 2016 --> Apr 2017
- || Trial primary completion date: An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD) (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=51, Recruiting, Sponsor: Enzymotec
N=30 --> 10 | Trial primary completion date: Apr 2016 --> Apr 2017 Trial primary completion date: Aug 2016 --> Dec 2016
- ||||| Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
Enrollment closed: Efficacy and Safety of Circadin (clinicaltrials.gov) - Jul 12, 2016
P3, N=125, Active, not recruiting, Sponsor: Neurim Pharmaceuticals Ltd.
Trial primary completion date: Aug 2016 --> Dec 2016 Recruiting --> Active, not recruiting
- New trial: Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children (APAUTRES) (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=140, Recruiting, Sponsor: University Hospital, Grenoble
- Biomarker, New trial: EpiTED: Developmental Trajectories in ASD Until Adulthood: A 15 Years Follow-up Study (clinicaltrials.gov) - Jul 11, 2016
P=N/A, N=106, Completed, Sponsor: University Hospital, Montpellier
- New trial: Validation of the French Adaptation of the RAADS-R Scale : Scale of Asperger Syndrome Diagnosis (clinicaltrials.gov) - Jul 7, 2016
P=N/A, N=324, Completed, Sponsor: University Hospital, Montpellier
- New trial: Electrodermal Patterns of Arousal in Children (clinicaltrials.gov) - Jun 29, 2016
P=N/A, N=32, Completed, Sponsor: Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy
- clonidine extended release / Generic mfg.
New P2 trial: Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder (clinicaltrials.gov) - Jun 24, 2016
P2, N=16, Not yet recruiting, Sponsor: Ohio State University
- Trial primary completion date: MGHTCT: Feasibility and Effectiveness of Computerized Cognitive Training in Adolescents With Autism Spectrum Disorder (clinicaltrials.gov) - Jun 20, 2016
P=N/A, N=30, Enrolling by invitation, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting Trial primary completion date: May 2016 --> Nov 2016
- New trial: Build Your Parenting Toolkit: Guiding Children to Become Flexible Thinkers (clinicaltrials.gov) - Jun 18, 2016
P=N/A, N=8, Not yet recruiting, Sponsor: Rehabilitation Centre for Children, Canada
- Trial completion: iPad Application to Treat Prosodic Deficits in Students With Communication Disorders (clinicaltrials.gov) - Jun 15, 2016
P=N/A, N=200, Completed, Sponsor: Yale University
Trial primary completion date: May 2016 --> Nov 2016 Active, not recruiting --> Completed
- | atomoxetine / Generic mfg.
Trial completion, Enrollment change: Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism (clinicaltrials.gov) - Jun 11, 2016
P3, N=60, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=86 --> 60
- New trial: Family Centered Occupational Therapy on Play Skills and Participation of Children With ASD (clinicaltrials.gov) - Jun 11, 2016
P=N/A, N=60, Recruiting, Sponsor: National Taiwan University Hospital
- Trial initiation date: Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety (clinicaltrials.gov) - Jun 9, 2016
P=N/A, N=40, Not yet recruiting, Sponsor: Emory University
Recruiting --> Completed | N=86 --> 60 Initiation date: Apr 2016 --> Jul 2016
- New trial: SEMATIC Pilot Study in Children With Autism Spectrum Disorder Using an Innovative Edutainment Software (clinicaltrials.gov) - Jun 9, 2016
P=N/A, N=17, Completed, Sponsor: Fondation Lenval
- || Trial primary completion date: Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort (clinicaltrials.gov) - May 27, 2016
P0, N=150, Recruiting, Sponsor: Janssen Research & Development, LLC
Initiation date: Apr 2016 --> Jul 2016 Trial primary completion date: Apr 2016 --> Oct 2016
- bisacodyl / Generic mfg.
Enrollment closed: An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders (clinicaltrials.gov) - May 23, 2016
P=N/A, N=22, Active, not recruiting, Sponsor: Emory University
Trial primary completion date: Apr 2016 --> Oct 2016 Recruiting --> Active, not recruiting
- Trial completion: The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children (clinicaltrials.gov) - May 19, 2016
P2, N=10, Completed, Sponsor: University of Johannesburg
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion, Trial primary completion date: Efficacy of Training Programme to Reduce Stress (clinicaltrials.gov) - May 18, 2016
P=N/A, N=67, Completed, Sponsor: University of Nottingham
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Dec 2015
- New trial: Neurofeedback Therapy for Children Diagnosed With Autism (clinicaltrials.gov) - May 16, 2016
P=N/A, N=64, Recruiting, Sponsor: Carrick Institute for Graduate Studies
- Enrollment closed, Trial primary completion date: Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders (clinicaltrials.gov) - May 13, 2016
P=N/A, N=40, Active, not recruiting, Sponsor: Universit
Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Dec 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Jun 2016
- Enrollment closed, Trial primary completion date: Metacognitive Self-regulated Learning and Sensory Integrative Approaches for Children With Autism Spectrum Disorders (clinicaltrials.gov) - May 12, 2016
P=N/A, N=60, Active, not recruiting, Sponsor: University of Western Sydney
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- Enrollment change, Trial suspension: A Study of the Association Between Autism and Immune Changes in the Brain (clinicaltrials.gov) - May 10, 2016
P=N/A, N=15, Suspended, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 N=60 --> 15 | Recruiting --> Suspended
- Phase classification: Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder (clinicaltrials.gov) - May 3, 2016
P1, N=24, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
N=60 --> 15 | Recruiting --> Suspended Phase classification: P2 --> P1
- |||||||||| Melatobel (melatonin) / Nobelpharma
New P2/3 trial: Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders (clinicaltrials.gov) - May 2, 2016
P2/3, N=180, Not yet recruiting, Sponsor: Nobelpharma
- ||| New trial: A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD (clinicaltrials.gov) - May 2, 2016
P=N/A, N=200, Enrolling by invitation, Sponsor: Newport Brain Research Laboratory
- New trial: Targeting Sleep in Kids With Autism Spectrum Disorder (clinicaltrials.gov) - Apr 28, 2016
P=N/A, N=30, Not yet recruiting, Sponsor: University of Missouri-Columbia
- Trial completion: Improving Hospitalizations for Children With ASD (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=36, Completed, Sponsor: Vanderbilt University
Phase classification: P2 --> P1 Enrolling by invitation --> Completed
- Trial completion: Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder (clinicaltrials.gov) - Apr 25, 2016
P=N/A, N=192, Completed, Sponsor: Boston Medical Center
Enrolling by invitation --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Transition Support Program for Young Adults With Autism Spectrum Disorders (clinicaltrials.gov) - Apr 22, 2016
P=N/A, N=28, Active, not recruiting, Sponsor: McGill University
Active, not recruiting --> Completed Trial primary completion date: May 2015 --> Jul 2016
- New trial: A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT (clinicaltrials.gov) - Apr 21, 2016
P=N/A, N=28, Enrolling by invitation, Sponsor: Newport Brain Research Laboratory
- Biomarker, Trial completion, Enrollment change: Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=25, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: May 2015 --> Jul 2016 Enrolling by invitation --> Completed | N=60 --> 25
- New trial: Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=68, Completed, Sponsor: The Cleveland Clinic
- | metformin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD) (clinicaltrials.gov) - Apr 14, 2016
P3, N=61, Completed, Sponsor: Evdokia Anagnostou
Enrolling by invitation --> Completed | N=60 --> 25 Active, not recruiting --> Completed | N=90 --> 61 | Trial primary completion date: Oct 2015 --> Jun 2015
- riluzole / Generic mfg.
Trial completion: RILISE: A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD (clinicaltrials.gov) - Apr 14, 2016
P2, N=58, Completed, Sponsor: Evdokia Anagnostou
Active, not recruiting --> Completed | N=90 --> 61 | Trial primary completion date: Oct 2015 --> Jun 2015 Active, not recruiting --> Completed
- memantine / Generic mfg.
Trial completion, Enrollment change: A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM) (clinicaltrials.gov) - Apr 14, 2016
P2, N=23, Completed, Sponsor: Evdokia Anagnostou
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=60 --> 23
- pioglitazone / Generic mfg.
Trial completion, Enrollment change: Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO) (clinicaltrials.gov) - Apr 14, 2016
P2, N=28, Completed, Sponsor: Evdokia Anagnostou
Active, not recruiting --> Completed | N=60 --> 23 Active, not recruiting --> Completed | N=35 --> 28
- Trial primary completion date: Emergence of Generative Language (clinicaltrials.gov) - Apr 12, 2016
P=N/A, N=6, Enrolling by invitation, Sponsor: Emory University
Active, not recruiting --> Completed | N=35 --> 28 Trial primary completion date: Mar 2016 --> Nov 2016